Comparative Effectiveness of Bariatric Surgery Versus GLP‐1 Receptor Agonists in Reducing the Risk of New‐Onset of NASH: A Retrospective Multinational Cohort Study From North America and Europe

ABSTRACT Background Nonalcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD) that can progress to cirrhosis and hepatocellular carcinoma (HCC). Obesity is a major risk factor for NASH, and metabolic interventions such as bariatric surgery (BS) and glucagon‐lik...

Full description

Bibliographic Details

Published in:	Endocrinology, Diabetes & Metabolism
Main Authors:	Abdallah Hussein, Ameer Awashra, Islam Rajab, Mohammad Bdair, Dawoud Hamdan, Ahmad Nouri, Elaf Khatib, Ghiras Khatib, Nyan Latt
Format:	Article
Language:	English
Published:	Wiley 2025-07-01
Subjects:	bariatric surgery GLP‐1 receptor agonists hepatocellular carcinoma liver cirrhosis metabolic dysfunction nonalcoholic steatohepatitis (NASH)
Online Access:	https://doi.org/10.1002/edm2.70075